Bradley L. Campbell - Dec 18, 2023 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
President and CEO, Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Stock symbol
FOLD
Transactions as of
Dec 18, 2023
Transactions value $
$0
Form type
4
Date filed
12/19/2023, 05:58 PM
Previous filing
Dec 5, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Award $0 +17.3K +2.18% $0.00 809K Dec 18, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a contingent right to receive common stock in the amount shown, for no consideration, due to the satisfaction of performance criteria underlying an award of performance based restricted stock units granted in 2021. Such units remain outstanding on the date hereof and will fully vest on December 31, 2023, subject to the Reporting Person's continued service with the Company.